Bifogade filer
Update on NeoDynamics’ management team
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Mats Gustafsson appointed CFO of NeoDynamics
Mats Gustafsson has today been appointed as the next CFO of NeoDynamics. Mats Gustafsson succeeds Aaron Wong, who will conclude his tenure with the company May 31st, 2024 as announced on 13 December 2023.
Mats Gustafsson is CFO of Salénia AB, part of the Salén Group. The Salén Group is also the owner of Salenterprise, the largest shareholder of NeoDynamics.
Mats Gustavssons education includes degrees in Law and Economics from Uppsala University and he has been working at Salénia since 2016. He has previously been CEO of Metsnik AB, CFO of Johnson Pump AB and CFO of TMT One AB.
For further information, please contact:
Matilda Salén, CEO NeoDynamics AB, phone +46 76-843 65 74 or e-mail matilda.salen@neodynamics.com
About NeoDynamics
NeoDynamics AB is a Swedish Medical Technology Company dedicated to advancing the diagnosis and care of cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound-guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institute in Sweden. NeoDynamics’ shares are listed on Nasdaq First North Growth Market Stockholm: NEOD.ST. The company’s Certified Adviser is Redeye AB.
About NeoNavia®
NeoNavia® is the first vacuum-assisted device utilizing pulse technology for high yield, low risk, targeted biopsies in the breast and axillary lymph nodes. The innovative platform provides 3 needle options designed for accurate lesion targeting and greater tissue sampling with minimal trauma to surrounding tissue.